Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 8:05 AM ET | Feedback | Site Changes | Help
A clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections.
View All Commentary (VRUS)
Recs
zzlangerhans (98.67) Submitted: 6/17/08 10:28 AM : Start Price: $20.14 VRUS Score: -5.10
No change in fundamentals. It just seems like we've drifted a little high and we're due for a correction. It's going to be a while before any significant positive catalysts.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK